Results 121 to 130 of about 2,992,232 (249)

Dynamically characterizing individual clinical change by the steady state of disease-associated pathway. [PDF]

BMC Bioinformatics, 2019
Sun S, Yu X, Sun F, Tang Y, Zhao J, Zeng T.   +5 more
europepmc   +1 more source

Provider fidelity and modifications to cognitive processing therapy in a diverse community health clinic: Associations with clinical change. [PDF]

J Consult Clin Psychol, 2019
Marques L, Valentine SE, Kaysen D, Mackintosh MA, Dixon De Silva LE, Ahles EM, Youn SJ, Shtasel DL, Simon NM, Wiltsey-Stirman S.   +9 more
europepmc   +1 more source

Is evidence-based treatment helping my patient? Utilizing modified Brinley plots to measure clinical change. [PDF]

Clin Psychol (New York), 2019
Black SR, Blampied N, Arnold LE, Fristad MA.   +3 more
europepmc   +1 more source

A Bibliometric Analysis of Publications in Uremic Toxins From 1991 to 2024

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Uremic toxins are a growing area of research in nephrology, with significant implications in the progression and treatment of chronic kidney disease (CKD) and the management of end‐stage kidney disease (ESKD). This bibliometric analysis aims to evaluate the global research trends, key contributors, and the impact of publications in ...
Yuh‐Shan Ho, Karim M. Soliman, Wisit Cheungpasitporn, Wannasit Wathanavasin, Ahmed Daoud, Ahmed I. Kamal, Balázs Szamosfalvi, Tibor Fülöp   +7 more
wiley   +1 more source

Designing for Clinical Change: Creating an Intervention to Implement New Statin Guidelines in a Primary Care Clinic. [PDF]

JMIR Hum Factors, 2018
DeJonckheere M, Robinson CH, Evans L, Lowery J, Lowery J, Youles B, Tremblay A, Kelley C, Sussman JB.   +8 more
europepmc   +1 more source

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye, Chimezie Okwuonu, Evelyn Idam, Folasade Adelekan‐Popoola, Shakirat Gold‐Olufadi, Olufunto Olufela Kalejaiye, Abdullateef Ogala, Zinnah Aloziem, Blossom Amamchukwu, Patience Elimia, Mkpoikanabasi Obot‐Obot, Henry Mbakwe, Praises Maduagwuna, Olatunji Akinrodoye, Chiamaka Anyanwu, Benjamin Anyanwu, Adedamola Akinsiku, Oluwatoyin A. Akinsiku, Muzamil O. Hassan, Fatiu A. Arogundade, Olalekan E. Ojo, Homayemem Weli, Jesupelumi Adenihun, Aderemi Adelaja, Ebun Bamgboye, Olalekan Olatise, Ade E. Faponle, Ayoola Odeyemi, Michael Muoka, Stephen Asaolu, Qudrat Busari, Blessing Dawudu, Michael Naiyeju, Rasheed A. Balogun   +33 more
wiley   +1 more source

Defining the transition from new to normal: a qualitative investigation of the clinical change process. [PDF]

BMC Health Serv Res
Silver SR, Jones KC, Hook K, Crable EL, George ER, Serwint JR, Austad K, Walkey A, Drainoni ML.   +8 more
europepmc   +1 more source

Detecting clinical change with the CDR-FTLD: differences between FTLD and AD dementia. [PDF]

Int J Geriatr Psychiatry, 2017
Mioshi E, Flanagan E, Knopman D.
europepmc   +1 more source

Experience With Performing Rheocarna Therapy via the Single‐Needle Method for Treatment of Chronic Limb‐Threatening Ischemia

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This study investigated the safety and efficacy of single‐needle Rheocarna therapy for chronic limb‐threatening ischemia (CLTI) with wounds. Methods Six patients with CLTI involving ulcers unresponsive to revascularization underwent single‐needle Rheocarna treatment.
Yasutaka Yamauchi, Rie Tanaka, Reona Kawahira, Shingo Nabeta, Kouhei Naoi, Kazuhito Kitajima, Akira Wada, Tomonari Takagi, Norihiko Ohura, Akira Miyamoto   +9 more
wiley   +1 more source

Assessment of feasibility of actigraphy as a measure of clinical change in response to an experimental interventional treatment in adolescents and adults with autism spectrum disorder. [PDF]

Front Psychiatry
Boice M, Bryant S, Klein M, Meyer M, Bangerter A, Vairavan S, Pandina G.   +6 more
europepmc   +1 more source